AP518A - Spirostanyl glycosidal crystalline monohydrate. - Google Patents
Spirostanyl glycosidal crystalline monohydrate. Download PDFInfo
- Publication number
- AP518A AP518A APAP/P/1994/000615A AP9400615A AP518A AP 518 A AP518 A AP 518A AP 9400615 A AP9400615 A AP 9400615A AP 518 A AP518 A AP 518A
- Authority
- AP
- ARIPO
- Prior art keywords
- crystalline
- compound
- water
- monohydrate
- hypercholesterolemia
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Vascular Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US5444993A | 1993-04-28 | 1993-04-28 |
Publications (2)
Publication Number | Publication Date |
---|---|
AP9400615A0 AP9400615A0 (en) | 1994-01-31 |
AP518A true AP518A (en) | 1996-08-23 |
Family
ID=21991141
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
APAP/P/1994/000615A AP518A (en) | 1993-04-28 | 1994-01-27 | Spirostanyl glycosidal crystalline monohydrate. |
Country Status (23)
Country | Link |
---|---|
US (1) | US5760009A (fi) |
EP (1) | EP0696292A1 (fi) |
JP (1) | JPH08504830A (fi) |
CN (1) | CN1121722A (fi) |
AP (1) | AP518A (fi) |
AU (1) | AU6295694A (fi) |
BG (1) | BG100098A (fi) |
BR (1) | BR9406332A (fi) |
CA (1) | CA2161239A1 (fi) |
CZ (1) | CZ280195A3 (fi) |
FI (1) | FI941942A (fi) |
HU (1) | HUT67142A (fi) |
IL (1) | IL109374A0 (fi) |
LV (1) | LV11475A (fi) |
MA (1) | MA23179A1 (fi) |
NO (1) | NO954322L (fi) |
OA (1) | OA10715A (fi) |
PL (1) | PL311278A1 (fi) |
SI (1) | SI9400203A (fi) |
SK (1) | SK135195A3 (fi) |
WO (1) | WO1994025479A1 (fi) |
YU (1) | YU22694A (fi) |
ZA (1) | ZA942772B (fi) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
US6150336A (en) * | 1995-05-29 | 2000-11-21 | Pfizer Inc. | Steroidal glycosides |
PT1066042E (pt) * | 1998-03-26 | 2006-12-29 | Phytopharm Plc | Saponinas esteroides para o tratamento de doença de alzheimer |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US6343258B1 (en) | 1999-08-13 | 2002-01-29 | ALEXIS Brian | Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
PE20011065A1 (es) | 2000-02-01 | 2001-11-21 | Procter & Gamble | Proceso para fabricar bisfosfonatos geminales |
PE20011061A1 (es) | 2000-02-01 | 2001-11-20 | Procter & Gamble | Cristalizacion selectiva del acido 3-piridil-1-hidroxi-etiliden-1,1-bisfosfonico sodio como el hemipentahidrato o el monohidrato |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
US6825960B2 (en) * | 2002-01-15 | 2004-11-30 | Inphase Technologies, Inc. | System and method for bitwise readout holographic ROM |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2926463A1 (de) * | 1978-07-05 | 1980-01-24 | Roecar Holdings Nv | Spiroketaline und ihre verwendung |
US4260603A (en) * | 1979-01-02 | 1981-04-07 | Pegel Karl H | Sterol glycoside with activity as prostaglandin synthetase inhibitor |
NZ193564A (en) * | 1979-05-02 | 1985-01-31 | Aruba Pty Ltd | Steroid alkaloids from solanum sodomeum and pharmaceutical compositions |
JPS56120700A (en) * | 1980-02-26 | 1981-09-22 | Wakunaga Yakuhin Kk | Cardiac stimmulant |
US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
US4602005A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
US5010185A (en) * | 1989-06-13 | 1991-04-23 | Pfizer Inc. | Processes for tigogenin beta-cellobioside |
ATE165367T1 (de) * | 1991-10-04 | 1998-05-15 | Procter & Gamble | Cholesterinsenkende verbindungen und verfahren zu ihrer herstellung |
JPH0826064B2 (ja) * | 1991-11-25 | 1996-03-13 | ファイザー インク. | ステロイドペルアシルグリコシド類の製法 |
BR9306619A (pt) * | 1992-06-26 | 1998-12-08 | Pfizer | Glicosídeos esteroidais para o tratamento da hipercolesterolemia |
US5530107A (en) * | 1992-10-15 | 1996-06-25 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
JP2767530B2 (ja) * | 1993-05-06 | 1998-06-18 | 花王株式会社 | 物品の集荷方法及び装置 |
-
1994
- 1994-01-19 PL PL94311278A patent/PL311278A1/xx unknown
- 1994-01-19 CN CN94191929A patent/CN1121722A/zh active Pending
- 1994-01-19 AU AU62956/94A patent/AU6295694A/en not_active Abandoned
- 1994-01-19 CZ CZ952801A patent/CZ280195A3/cs unknown
- 1994-01-19 WO PCT/US1994/000446 patent/WO1994025479A1/en not_active Application Discontinuation
- 1994-01-19 BR BR9406332A patent/BR9406332A/pt not_active Application Discontinuation
- 1994-01-19 CA CA002161239A patent/CA2161239A1/en not_active Abandoned
- 1994-01-19 US US08/532,571 patent/US5760009A/en not_active Expired - Fee Related
- 1994-01-19 JP JP6524222A patent/JPH08504830A/ja active Pending
- 1994-01-19 SK SK1351-95A patent/SK135195A3/sk unknown
- 1994-01-19 EP EP94910645A patent/EP0696292A1/en not_active Withdrawn
- 1994-01-27 AP APAP/P/1994/000615A patent/AP518A/en active
- 1994-04-21 ZA ZA942772A patent/ZA942772B/xx unknown
- 1994-04-21 IL IL10937494A patent/IL109374A0/xx unknown
- 1994-04-27 FI FI941942A patent/FI941942A/fi not_active Application Discontinuation
- 1994-04-27 HU HU9401209A patent/HUT67142A/hu unknown
- 1994-04-27 MA MA23485A patent/MA23179A1/fr unknown
- 1994-04-27 YU YU22694A patent/YU22694A/sh unknown
- 1994-04-28 SI SI9400203A patent/SI9400203A/sl unknown
-
1995
- 1995-10-26 BG BG100098A patent/BG100098A/bg unknown
- 1995-10-27 OA OA60729A patent/OA10715A/en unknown
- 1995-10-27 NO NO954322A patent/NO954322L/no unknown
- 1995-10-30 LV LV950325A patent/LV11475A/xx unknown
Also Published As
Publication number | Publication date |
---|---|
HUT67142A (en) | 1995-02-28 |
BR9406332A (pt) | 1995-12-26 |
US5760009A (en) | 1998-06-02 |
CN1121722A (zh) | 1996-05-01 |
IL109374A0 (en) | 1994-07-31 |
ZA942772B (en) | 1995-10-23 |
PL311278A1 (en) | 1996-02-05 |
JPH08504830A (ja) | 1996-05-28 |
FI941942A (fi) | 1994-10-29 |
AP9400615A0 (en) | 1994-01-31 |
SK135195A3 (en) | 1996-03-06 |
CA2161239A1 (en) | 1994-11-10 |
NO954322D0 (no) | 1995-10-27 |
EP0696292A1 (en) | 1996-02-14 |
HU9401209D0 (en) | 1994-08-29 |
FI941942A0 (fi) | 1994-04-27 |
AU6295694A (en) | 1994-11-21 |
WO1994025479A1 (en) | 1994-11-10 |
NO954322L (no) | 1995-10-27 |
OA10715A (en) | 2002-12-09 |
SI9400203A (en) | 1995-06-30 |
LV11475A (lv) | 1996-08-20 |
MA23179A1 (fr) | 1994-12-31 |
YU22694A (sh) | 1997-03-07 |
BG100098A (bg) | 1996-04-30 |
CZ280195A3 (en) | 1996-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5703052A (en) | Sterodial glycosides for treating hypercholesterolemia | |
AP518A (en) | Spirostanyl glycosidal crystalline monohydrate. | |
GB1599863A (en) | Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid | |
GB2068382A (en) | 25-hydroxy-26,26,26,27,27,27-hexafluorocholecalciferol | |
JPH01156995A (ja) | 新規なアンドロスタン17−カルボン酸エステル、その製法及びそれを含む薬剤 | |
US4332797A (en) | Chlorambucil derivatives | |
US6150336A (en) | Steroidal glycosides | |
US5804562A (en) | Spirostanyl glycosidal crystals | |
DD266801A5 (de) | Verfahren zur herstellung einer oestrogen wirksamen verbindung | |
CA1255293A (en) | 2-oxa- or -aza-pregnane compounds | |
NZ200779A (en) | 4-alpha,5-alpha-epoxy-3,20-dioxopregnane-2-alpha | |
EP0430386A1 (de) | 14Alpha, 17alpha-überbrückte 16-Hydroxyestratriene | |
JPS635097A (ja) | アンドロスト−4−エン−3,17−ジオンのメチレン誘導体およびその製造方法 | |
KR20030090207A (ko) | 결장표적성 프로드럭으로서의 코티코스테로이드21-설페이트 소듐 유도체 | |
HU181845B (en) | Process for producing delta-4,9 above-pregnane derivatives | |
NO945001L (no) | Steroide glykosider for behandling av hyperkolestrolemi |